This compound is a pharmaceutical intermediate featuring an azetidine ring with a hydroxymethyl substituent and a tert-butoxycarbonyl protecting group. It is primarily used in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 142253-56-3
2,6-Heptadienoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-, (2Z,5S,6E)-
pharmaceutical intermediate
6-~{tert}-Butyl-8-Fluoranyl-2-[3-(Hydroxymethyl)-4-[1-Methyl-5-[[5-(1-Methylpiperidin-4-Yl)pyridin-2-Yl]amino]-6-Oxidanylidene-Pyridazin-3-Yl]pyridin-2-Yl]phthalazin-1-One
pharmaceutical intermediate
2,2-Dimethylpropanoic acid [[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]ethoxyphosphinyl]oxy]methyl ester
pharmaceutical intermediate
6-(Boc-amino)hexyl bromide
pharmaceutical intermediate
1-N-Boc-3-hydroxyazetidine
pharmaceutical intermediate
1-Boc-3-iodoazetidine
pharmaceutical intermediate
3-Methoxyazetidine hydrochloride
research compound
1-Boc-L-azetidine-2-carboxylic acid
pharmaceutical intermediate
tert-butyl 3-(hydroxymethyl)azetidine-1-carboxylate
HXRDRJKAEYHOBB-UHFFFAOYSA-N
CC(C)(C)OC(=O)N1CC(C1)CO